Showing results (201-210 of 219) with videos related to

Sort By:
Pageof 22
BMC Cancer|March 24, 2023
Tolerability of concurrent external beam radiotherapy and [177Lu]Lu-PSMA-617 for node-positive prostate cancer in treatment naïve patients, phase I study (PROQURE-I trial)Esmée C A van der Sar, Arthur J A T Braat, Jochem R N van der Voort-van Zyp, et al.
Oncotarget|December 15, 2016
Quantitative assessment of Zirconium-89 labeled cetuximab using PET/CT imaging in patients with advanced head and neck cancer: a theragnostic approachAniek J G Even, Olga Hamming-Vrieze, Wouter van Elmpt, et al.
The British Journal of Radiology|March 21, 2025
Imaging of Cancer of Unknown Primary: a systematic literature review of the past, present, and futureSajjad Rostami, Hannah W Stutterheim, Olga Maxouri, et al.
Practical Radiation Oncology|May 4, 2021
68Ga-PSMA-11 PET, 18F-PSMA-1007 PET, and MRI for Gross Tumor Volume Delineation in Primary Prostate Cancer: Intermodality and Intertracer VariabilityCédric Draulans, Floris Pos, Robert J Smeenk, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 15, 2024
Intra-prostatic recurrences after radiotherapy with focal boost: Location and dose mapping in the FLAME trialK Menne Guricová, F J Pos, I G Schoots, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 25, 2020
The tubarial salivary glands: A potential new organ at risk for radiotherapyMatthijs H Valstar, Bernadette S de Bakker, Roel J H M Steenbakkers, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 27, 2026
PROQURE-I: a phase I study adding concurrent [177Lu]Lu-PSMA-617 to EBRT and ADT in curative intent treatment of N1 prostate cancerLotte G Zuur, Denise S Hoogenkamp, Esmée C A van der Sar, et al.
European Heart Journal|February 19, 2026
Delirium in cardiovascular medicineEndrit Cekaj, David H V Vogel, Peter M Spieth, et al.
EJNMMI Physics|March 17, 2026
Smart scanning for two: [18F]FDG dose optimization for pregnant patients using LAFOV PET/CT technologyIlja S Deurloo, Milou M Steemers-de Boer, Johannes H van Snick, et al.
Plos One|July 1, 2025
[18F]FDG PET/CT to reduce the need for sentinel lymph node biopsy in early-stage oral cancer: PETN0-study protocolRoosmarijn S Tellman, Dominique N V Donders, Anne I J Arens, et al.
Pageof 22